David A. Bond

University of Iowa

H指数:23

被引数:2,441

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma

比较新型与传统化疗方案对复发性和难治性经典霍奇金淋巴瘤的疗效

Clinical Lymphoma Myeloma & Leukemia

IF2.7

2026-05-010

PRE

Hodgkin Lymphoma, Version 1.2026

霍奇金淋巴瘤，版本1.2026

Journal of the National Comprehensive Cancer Network

IF16.4

2026-02-011

PRE

Advani, Ranjana H.; Kelsey, Christopher R.; Armand, Philippe; Bello, Celeste M.; Benitez, Cecil M.; Bond, David; Chen, Weina; Cherian, Sheen; Czader, Magdalena; Dabaja, Bouthaina; Daly, Megan E.; Frosch, Zachary; Gordon, Leo I.; Hansen, Neil; Herrera, Alex F.; Hochberg, Ephraim P.; Hoppe, Richard T.; Isufi, Iris; Johnston, Patrick B.; Kelly, Kara; Kenkre, Vaishalee P.; Kline, Justin; Lynch, Ryan C.; McConathy, Jonathan; Morgan, David; Niu, Alex; Paul, Suman; Rabinovitch, Rachel; Salavati, Ali; Sano, Dahlia; Shah, Harsh; Spinner, Michael; Svoboda, Jakub; Winter, Jane N.; Yahalom, Joachim; Yang, Joanna C.; Montgomery, Sarah; Stehman, Katie

Clinical characteristics associated with terminal methotrexate clearance in patients with non-Hodgkin lymphomas receiving high-dose methotrexate

非霍奇金淋巴瘤患者接受大剂量甲氨蝶呤治疗时与末相甲氨蝶呤清除率相关的临床特征

Journal of Oncology Pharmacy Practice

IF0.9

2026-02-010

PRE

Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell Lymphoma

利妥昔单抗维持治疗在一线苯达莫司汀联合利妥昔单抗治疗后滤泡性淋巴瘤患者中的获益

Blood Advances

IF7.1

2025-12-150

OAAI

A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation

一项关于Duvelisib与Nivolumab联合治疗弥漫性大B细胞淋巴瘤、转化性滤泡性淋巴瘤和Richter转化的I期研究

EUROPEAN JOURNAL OF HAEMATOLOGY

IF2.3

2025-12-010

PRE

MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma

微小残留病驱动的阿卡替尼联合来那度胺与利妥昔单抗（ALR）或奥比妥珠单抗（ALO）初始治疗套细胞淋巴瘤

Blood Advances

IF7.1

2025-11-270

OAAI

Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure

基于先前CD19定向CAR T暴露的大B细胞淋巴瘤中Tafasitamab和Lenalidomide的治疗效果

HEMASPHERE

IF14.6

2025-11-180

OAAI

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era

现代时期核型评估在Richter转化患者中的预后意义

American Journal of Hematology

IF9.9

2025-07-020

PRE

Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma

嵌合抗原受体T细胞疗法后的急性肾损伤与复发/难治性大B细胞淋巴瘤患者的较差生存率相关

British Journal of Haematology

IF3.8

2025-06-300

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies

血液恶性肿瘤患者接受CAR T细胞疗法后的第二原发恶性肿瘤

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2025-03-180

Umyarova, Elvira; Pei, Charles; Pellegrino, William; Zhao, Qiuhong; Sharma, Nidhi; Benson, Don; Cottini, Francesca; Bezerra, Evandro; Brammer, Jonathan; Bumma, Naresh; Choe, Hannah; Denlinger, Nathan; Devarakonda, Srinivas; Khan, Abdullah; Penza, Sam; Rosko, Ashley; Vasu, Sumithira; Wall, Sarah; Alinari, Lapo; Baiocchi, Robert; Bond, David A.; Christian, Beth; Hanel, Walter; Maddocks, Kami; Reneau, John; Sawalha, Yazeed; Habib, Alma; Sigmund, Audrey; Voorhees, Timothy J.; de Lima, Marcos; Epperla, Narendranath

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

未接受过既往化疗免疫疗法治疗的Richter转化CLL患者的结局

BLOOD CANCER JOURNAL

IF11.6

2025-02-201

Kittai, Adam S.; Huang, Ying; Miller, Sarah; Allan, John N.; Bhat, Seema A.; Bond, David A.; Brander, Danielle M.; Byrd, John C.; Chavez, Julio C.; Chong, Elise; Davids, Matthew S.; Danilov, Alexey V.; Ding, Wei; Dowling, Mark R.; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J.; Ho, Carrie; Hwang, Steven R.; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A.; Parry, Erin; Rabe, Kari G.; Raess, Philipp W.; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A.; Saha, Aditi; Schade, Jake; Scott, Hamish W.; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M.; Thompson, Meghan C.; Thompson, Philip A.; Wang, Yucai; Yano, Max; Woyach, Jennifer A.

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma

新诊断的原发性弥漫性大B细胞淋巴瘤患者中，循环淋巴瘤细胞在诊断时对预后的影响

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2025-01-050

MRD-Driven Time-Limited Therapy of Acalabrutinib and Lenalidomide Plus Rituximab (ALR) or Obinutuzumab (ALO) in Patients with Treatment-Naive Mantle Cell Lymphoma: Phase 2 Trial Outcomes with MRD and cfDNA Analyses

MRD驱动的有限疗程Acalabrutinib联合Lenalidomide和Rituximab（ALR）或Obinutuzumab（ALO）治疗初治套细胞淋巴瘤患者的疗效：含MRD和cfDNA分析的II期试验结果

BLOOD

IF23.1

2024-11-051

PRE

Hodgkin Lymphoma Transformation in Patients Who Received No Prior Chemotherapy for CLL/SLL: Outcomes from a Multicenter Retrospective Study in the Modern Era of Therapy

霍奇金淋巴瘤转化：在接受过无既往化疗的CLL/SLL患者中的转化结局——来自现代治疗时代的多中心回顾性研究

BLOOD

IF23.1

2024-11-050

PRE

Hampel, Paul J.; Huang, Ying; Miller, Sarah; Allan, John N.; Bhat, Seema A.; Bond, David A.; Brander, Danielle M.; Byrd, John C.; Chavez, Julio C.; Chong, Elise A.; Danilov, Alexey; Davids, Matthew S.; Dvorak-Kornaus, Kaitlyn M.; Freedman, Hannah; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Parikh, Sameer A.; Parry, Erin M.; Rabe, Kari G.; Raess, Phil; Rai, Manoj; Rhodes, Joanna M.; Rogers, Kerry A.; Saha, Aditi; Schade, Jake; Shouse, Geoffrey; Spurgeon, Stephen E.; Stephens, Deborah M.; Wang, Yucai; Woyach, Jennifer A.; Yano, Max; Zulfa, Omer; Kittai, Adam S.

A Phase I/II Study of Tazemetostat Combined with Abbreviated Rituximab/Bendamustine Therapy for High Tumor Burden Follicular Lymphoma in Frontline Treatment: A Big Ten Cancer Research Consortium Study

一项Tazemetostat联合简化利妥昔单抗/苯达莫司汀方案治疗一线高肿瘤负荷滤泡性淋巴瘤的I/II期研究：一项Big Ten癌症研究联盟研究

BLOOD

IF23.1

2024-11-050

PRE

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

BLOOD ADVANCES

IF7.1

2024-10-110

PRE

Epperla, Narendranath; Zayac, Adam S.; Landsburg, Daniel J.; Bock, Allison M.; Nowakowski, Grzegorz S.; Ayers, Emily C.; Girton, Mark; Hu, Marie; Beckman, Amy; Li, Shaoying; Medeiros, L. Jeffrey; Chang, Julie E.; Kurt, Habibe; Sandoval-Sus, Jose; Ansari-Lari, Mohammad Ali; Kothari, Shalin K.; Kress, Anna; Xu, Mina L.; Torka, Pallawi; Sundaram, Suchitra; Smith, Stephen D.; Naresh, Kikkeri N.; Karimi, Yasmin; Bond, David A.; Evens, Andrew M.; Naik, Seema G.; Kamdar, Manali; Haverkos, Bradley M.; Karmali, Reem; Farooq, Umar; Vose, Julie M.; Rubinstein, Paul; Chaudhry, Amina; Olszewski, Adam J.

Postinfusion PD-1+CD8+CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma

BLOOD ADVANCES

IF7.1

2024-06-131

OAAI

Denlinger, Nathan; Song, No-Joon; Zhang, Xiaoli; Jeon, Hyeongseon; Peterson, Chelsea; Wang, Yi; Reynolds, Kelsi; Bolz, Robert M.; Miao, Jessica; Song, Chunhua; Wu, Dayong; Chan, Wing Keung; Bezerra, Evandro; Epperla, Narendranath; Voorhees, Timothy J.; Brammer, Jonathan; Kittai, Adam S.; Bond, David A.; Sawalha, Yazeed; Sigmund, Audrey; Reneau, John C.; Rubinstein, Mark P.; Hanel, Walter; Christian, Beth; Baiocchi, Robert A.; Maddocks, Kami; Alinari, Lapo; Vasu, Sumithira; de Lima, Marcos; Chung, Dongjun; Jaglowski, Samantha; Li, Zihai; Huang, Xiaopei; Yang, Yiping

Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients

HEMATOLOGICAL ONCOLOGY

IF3.9

2024-05-100

PRE

Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma

BLOOD ADVANCES

IF7.1

2023-12-135

OAAI

Gerson, James N.; Handorf, Elizabeth; Villa, Diego; Gerrie, Alina S.; Chapani, Parv; Li, Shaoying; Medeiros, Jeffrey; Wang, Michael; Cohen, Jonathon B.; Churnetski, Michael; Hill, Brian T.; Sawalha, Yazeed; Hernandez-Ilizaliturri, Francisco J.; Kothari, Shalin; Vose, Julie M.; Bast, Martin; Fenske, Timothy; Gari, Swapna Narayana Rao; Maddocks, Kami J.; Bond, David; Bachanova, Veronika; Kolla, Bhaskar; Chavez, Julio; Shah, Bijal; Lansigan, Frederick; Burns, Timothy; Donovan, Alexandra M.; Wagner-Johnston, Nina; Messmer, Marcus; Mehta, Amitkumar; Anderson, Jennifer K.; Reddy, Nishitha; Kovach, Alexandra E.; Landsburg, Daniel J.; Glenn, Martha; Inwards, David J.; Ristow, Kay; Karmali, Reem; Kaplan, Jason B.; Caimi, Paolo F.; Rajguru, Saurabh; Evens, Andrew; Klein, Andreas; Umyarova, Elvira; Pulluri, Bhargavi; Amengua, Jennifer E.; Lue, Jennifer K.; Diefenbach, Catherine; Fisher, Richard I.; Barta, Stefan K.

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

BLOOD ADVANCES

IF7.1

2023-10-2512

OAAI

Zayac, Adam S.; Landsburg, Daniel J.; Hughes, Mitchell E.; Bock, Allison M.; Nowakowski, Grzegorz S.; Ayers, Emily C.; Girton, Mark; Hu, Marie; Beckman, Amy K.; Li, Shaoying; Medeiros, L. Jeffrey; Chang, Julie E.; Stepanovic, Adam; Kurt, Habibe; Sandoval-Sus, Jose; Ansari-Lari, M. Ali; Kothari, Shalin K.; Kress, Anna; Xu, Mina L.; Torka, Pallawi; Sundaram, Suchitra; Smith, Stephen D.; Naresh, Kikkeri N.; Karimi, Yasmin H.; Epperla, Narendranath; Bond, David A.; Farooq, Umar; Saad, Mahak; Evens, Andrew M.; Pandya, Karan; Naik, Seema G.; Kamdar, Manali; Haverkos, Bradley; Karmali, Reem; Oh, Timothy S.; Vose, Julie M.; Nutsch, Heather; Rubinstein, Paul G.; Chaudhry, Amina; Olszewski, Adam J.

David A. Bond

个人简介

教育背景

工作经历

荣誉奖项

研究方向